Generic abortion pill maker sues FDA over its response to orders halting drug's approval | News Channel 3-12

Contributing sentiments towards policy:

60% : The Supreme Court is currently considering whether to freeze the court orders that emerged from a separate lawsuit, filed by anti-abortion activists in Texas, that would undo the 2019 approval of the generic version of the drug and reverse other steps the FDA has taken in recent years to make abortion pills easier to obtain.
48% : The company alleges that the agency did not offer those assurances, nor did it respond to the company's requests for a non-enforcement directive that would shield the company, its business partners and its customers from any FDA enforcement actions based on the court orders in the Texas case."GenBioPro faces a credible, serious threat of FDCA enforcement if it attempts to continue producing and marketing mifepristone," the lawsuit says, referring to the Food, Drug, and Cosmetic Act, which sets out how the FDA goes about its regulatory process.
42% : "With the specter of criminal prosecution looming, GenBioPro may be obligated to undertake recalls, cancel contracted manufacturing and hold or destroy perishable inventory."

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.